Kobayashi Pharmaceutical Atnon EX Series

Features

A scar is a condition in which redness and swelling remain at the wound site due to abnormal proliferation of skin tissue when the wound is repaired. <br>Attonon contains three effective ingredients that will heal scars. (1) Heparinoids promote cell turnover and promote normal skin regeneration. (2) Allantoin repairs damaged skin tissue.
(3) GK2* soothes residual inflammation in scars. *Dipotassium glycyrrhizinate <br>By continuing to apply it while keeping in mind the skin's turnover, it will gradually work on scars.

[Class 2 OTC drug]

Efficacy and effectiveness

Lumps and tightness of the skin after wounds or burns (excluding the face), keratosis of the elbows, knees, heels, and ankles, dry fingers, cracks and chapped hands and feet, xerosis, dry skin in children, chilblains (excluding sores), swelling after bruises or sprains, muscle pain, and joint pain

<Notes regarding efficacy and effectiveness>

Dosage and Administration

Rub an appropriate amount onto the affected area, or spread it on gauze and apply it once or several times a day.

<Caution regarding dosage and administration>

(1) Close the cap tightly after each use. (2) Children should use the drug under the supervision of a parent or guardian. (3) Be careful not to get it in your eyes. If the product gets into your eyes, immediately rinse with water or lukewarm water. If symptoms are severe, consult an ophthalmologist. (4) For external use only

Ingredients and quantities

Per 100g <br>Heparinoids 0.3g
Allantoin 0.2g
Dipotassium glycyrrhizinate 1g

[Additives]

Hypromellose (hydroxypropyl methylcellulose), carboxyvinyl polymer, propylene glycol, isopropanol, triisopropanolamine, fragrance

<Notes regarding ingredients and quantities>

Dosage form

Gel (for external use - other)

Usage notes

■Things you shouldn't do (If you do not follow these instructions, your current symptoms may worsen or you may be more susceptible to side effects.)
1. The following people should not use this product: (1) People with bleeding blood disorders (hemophilia, thrombocytopenia, purpura, etc.) (2) People for whom even slight bleeding may cause serious consequences (the drug has a blood coagulation inhibitory effect and may promote bleeding).
2. Do not use in the following areas Eyes and areas around the eyes, mucous membranes (e.g. oral cavity, nasal cavity, vagina, etc.)
■Things to consult about
1. The following people should consult a doctor, pharmacist, or registered distributor before use. (1) People receiving medical treatment from a doctor
(2) People who have experienced allergic symptoms due to medicine, etc. (3) People with severe sores or wetness
2. If the following symptoms occur after use, these may be side effects, so discontinue use immediately and consult a doctor, pharmacist, or registered distributor with this document. [Affected area: Symptoms]
Skin: rash, redness, itchiness, swelling
3. If symptoms do not improve after 5 to 6 days of use, discontinue use and consult a doctor, pharmacist, or registered distributor with this leaflet.

Storage and handling precautions

(1) Store in a tightly sealed container in a cool, dry place away from direct sunlight. (2) Keep out of reach of children. (3) Do not transfer to other containers (this may lead to misuse or change the quality)